Emergent BioSolutions, Inc. (NYSE:EBS) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Matt Hartwig - Investor Relations Haywood Miller - Interim Chief Executive Officer Richard Lindahl - Executive Vice President, Chief Financial Officer & Treasurer Paul Williams - Senior Vice President, Products Business Conference Call Participants Joichi Sakai - Singular Research Nicholas Lorusso - TD Cowen Operator Good day and thank you for standing by. Welcome to the Q2 2023 Emergent Bi ...